|
|
 |
|
Viewing report
|
|
|
|
The Year in Schizophrenia Volume 2
Clinical Publishing, Oct 2008, Pages: 304
Schizophrenic disorders, of which at least five separate kinds are now recognised, remain difficult to diagnose and still harder to treat. This second volume reviews the most important work published in the last year, with expert comment and analysis from two of the leading authorities in the field. The editors review the latest advances in our understanding of the biochemical basis of the disease, its detection and diagnosis, and its relationship to other co-existent mental illness. There is up-to-date coverage of psychopharmacological agents and expert comment on recent advances in neurological aspects. In addition, this volume also includes discussion of cognitive and negative symptoms therapies, and psychosocial treatments. The Year in Schizophrenia enables the reader to keep up to date with the therapeutic options available, and maintain a better informed perspective on current opinion. It should find a place in the office of every doctor involved in the study and treatment of this complex and challenging disorder.
Benefits:
- Evaluation and critical appraisal of the full range of published literature in the field
- Key papers for practice identified and summarised
- Single user-friendly volume
- Draws on the experience of leading authorities
Readership:
- Psychiatrists
- Neurologists
- General physicians
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
The Year in Schizophrenia Volume 1
Schizophrenia, 3rd Edition
Bipolar Disorder: Clinical and Neurobiological Foundations
Royalty Rates for Pharmaceuticals & Biotechnology, 7th Edition
Bipolar Disorder - Global Strategic Business Report
The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
The Central Nervous Systems Market 2010 Report
The Neurotechnology Industry 2011 Report
The Handbook of Alzheimer's Disease and Other Dementias
|
|
|
|
